FDA inspection
Eagle Pharmaceuticals, Inc.: FDA inspection ending Oct 13, 2023
FDA inspection 1220703 · No Action Indicated (NAI) · Woodcliff Lake, NJ
Key facts
| Inspection ID | 1220703 |
|---|---|
| Firm | Eagle Pharmaceuticals, Inc. |
| FEI number | 3011077747 |
| Address | 50 Tice Blvd Ste 315 |
| City | Woodcliff Lake |
| State | NJ |
| ZIP | 07677 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Oct 13, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data